Company
Company

Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

CRISPR QC

Main focus: CRISPR gene-editing quality control

Company stage: Pre-clinical

Diseases (gene editing): Sickle-cell disease, genetic blindness, amyloidosis (ATTR), type I diabetes

Genome editing tool: CRISPR/Cas9

Funding stage: Private

Location: San Diego, California, USA

Website: https://www.crisprqc.com/?hsLang=en

CRISPR QC provides unique insights on CRISPR mechanics (i.e. cleavage activity, gRNA binding, complex stability), allowing therapeutic companies to optimize gene-editing outcomes.

Tags

HashtagCompany FeaturedHashtagCRISPRQC

Company: CRISPR QC
close
Search CRISPR Medicine